The purpose of this trial is to test if treatment with the trial drug, Vixarelimab, can reduce pruritus (ITCH) in people who have Prurigo Nodularis (P.N.). Basic criteria are listed below. Click to sign up or request more info.
Volunteers needed for a 20 week long clinical trial with up to 5 office visits for an injectable investigational product (vixarelimab) . Up to $875.00 stipend available. Additional stipend is available (see Information and Consent form or ask the Study Coordinator at your in-office screening visit).
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) 18 to 75 years of age
2.) Have Prurigo Nodularis (P.N.) with at least 20 nodules
3.) Moderate to Severe Pruritus (ITCH) associated with your P.N.
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Using medications that cause Pruritus (ITCH) and not willing to discontinue for duration of trial
2.) History of Hepatitis B, Hepatitis C, or HIV
3.) Have severe allergic reaction to any foods or medications (including anaphylactic reactions)
ClinicalTrials.gov Identifier: NCT03816891
We love our patients, so feel free to visit during normal business hours.
820 S McClellan Suite 414 Spokane, WA 99204
(509) 474-1107 (Dermatology)
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Prurigo Nodularis IIb Study Flyer. IRB Approved
Copyright © 2023 Principle Research Solutions,llc - All Rights Reserved.
Your One-Stop Research SOLUTION